Medical Devices

A new study reveals an AI-powered metric better predicts sleep apnea symptoms than traditional tests, promising more accurate diagnoses, especially for women.

After a dominant 2025, Planet DDS is shifting from cloud leader to AI pioneer, promising to automate workflows for the growing DSO market.

A new medical device enters real-world trials, promising to solve a critical failure point in dialysis grafts and improve life for millions of patients.

As its promising prostate cancer drug nears Phase 3, Convergent Therapeutics hires a new CPO to build the team for its next critical growth phase.

BioBridges and its legacy brands consolidate into Peritia, a new end-to-end platform designed to accelerate product development for resource-strapped teams.

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.

A new study in Nature Medicine shows a fasting-mimicking diet led to high remission rates in Crohn's patients, heralding a new era for 'Food as Medicine'.

Finnish firm GlucoModicum publishes research validating its needle-free tech, a major step toward ending painful finger pricks for diabetes management.

Curitics Health Solutions' new AI platform targets administrative bloat, promising to free clinicians from paperwork and speed up patient care approvals.

Top scientists, survivors, and industry leaders are uniting to accelerate a new generation of cancer vaccines, moving them from lab to patient faster than ever.

Amid federal funding threats, state leaders and industry forge a strategic alliance to protect Connecticut’s $7B life sciences sector and fuel innovation.

A new partnership combines radiation-free imaging with advanced AI analytics, aiming to revolutionize breast cancer detection and patient care.

ENNOVI's Tijuana expansion offers a key nearshoring solution for medical device makers, tackling complex regulations and streamlining North American supply chains.

A Norwegian firm's new AI software aims to reduce physician distractions and build trust, setting a new standard for cancer-detecting technology.

China approves Libevitug, a first-in-class drug for the most severe form of hepatitis, marking a major milestone for patients and global biotech innovation.

With drug pipelines facing staggering failure rates, HKeyBio's new preclinical strategy aims to de-risk R&D and accelerate effective new treatments.

A strategic investment from Krieger Capital will fuel Global Key Solutions' AI platform, which transforms complex regulatory data into actionable safety insights.

Fresh analyst coverage signals a potential rebirth for the med-tech firm after a major financial restructuring. But why do experts disagree on its value?

A new report details a dramatic rise in ransomware and supply chain attacks, turning digital threats into life-or-death crises for the global health sector.

With cardiac arrest striking every 9 minutes, a Québec foundation calls for a new law, citing a 29,000-defibrillator gap to ensure survival isn't left to chance.